藏药多刺绿绒蒿的化学和药理学研究进展

发布时间：2018-01-14 16:04

本文关键词：藏药多刺绿绒蒿的化学和药理学研究进展　出处：《中国中药杂志》2017年19期 　论文类型：期刊论文

【摘要】：多刺绿绒蒿是罂粟科绿绒蒿属的一种高山植物,局限分布于喜马拉雅山区域。多刺绿绒蒿既是一种珍稀高山花卉,又是一种藏族传统习用药材,为40余种藏药复方所收录,其具有清热止痛、活血化瘀等功效,用于骨折、跌打损伤、胸背疼痛等症。现代研究表明多刺绿绒蒿含有生物碱、黄酮、萜类等成分,初步药理研究证明其具有一定抗肿瘤、抗病毒、心肌保护等功效。然而受多种因素影响,当前对多刺绿绒蒿的研究还面临不少挑战。该文对多刺绿绒蒿的生态资源、传统药效、化学成分和药理作用研究进行归纳总结,以期为多其生态保护和应用研究,提供有益参考。
[Abstract]:Artemisia przewalskii is a kind of alpine plant of the genus Artemisia in the opium poppy family, which is limited to the Himalayan region. It is a rare alpine flower as well as a traditional Tibetan medicinal material. It is collected by more than 40 kinds of Tibetan medicine compound, which has the functions of clearing away heat and relieving pain, activating blood circulation and removing blood stasis, and is used for fracture, injury, chest and back pain, etc. Modern studies show that Artemisia spp contains alkaloids and flavonoids. Terpenoids and other components, preliminary pharmacological studies prove that it has some anti-tumor, anti-virus, myocardial protection and other functions. However, it is affected by a variety of factors. At present, there are still many challenges in the study of Artemisia spp. The ecological resources, traditional pharmacodynamics, chemical constituents and pharmacological effects of Artemisia polyphylla were summarized and summarized in this paper. In order to provide useful reference for more ecological protection and application research.
【作者单位】：北京中医药大学中药学院中药现代研究中心;
【基金】：国家自然科学基金项目(81303309,81774001)
【分类号】：R29
【正文快照】： 绿绒蒿属Meconopsis是罂粟科中仅次于紫堇属和罂粟属的第三大类别,为一年或多年生草本植物,全世界共有54种,除欧洲绿绒蒿M.cambrica产在西欧,其他53种都分布在喜马拉雅山地区,我国有43种,多分布在西藏、青海、云南等地[1-3]。据最新统计,本属植物共有18种入药,具有清热解毒、

【相似文献】